Cidara Therapeutics Competitors and Similar CompaniesClear all

Cidara Therapeutics's competitors and similar companies include Vertex Pharmaceuticals, CSL Behring, Cadila Pharmaceuticals and YiChang HEC ChangJiang Pharmaceutical.

	Cidara Therapeutics Cidara is biotechnology focused on developing novel anti-infectives to address serious infections.	Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.	CSL Behring CSL Behring is a provider of life-saving medicines.	Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.	YiChang HEC ChangJiang Pharmaceutical YiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products.
Founding Date	Founding Date 2013	Founding Date 1989	Founding Date 1904	Founding Date 1951	Founding Date 2001
Type	Type Public	Type Public	Type Subsidiary	Type Private	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations San Diego, US HQ	Locations Boston, US HQ St Leonards, AU Wien, AT Bruxelles, BE São Paulo, BR Toronto, CA Praha, CZ see more	Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more	Locations Bavla, IN HQ Akaki, ET Dholka, IN Chiyoda City, JP Nairobi, KE Moskva, RU Ascot, GB see more	Locations HQ
Employees	Employees 68	Employees 5,40013% increase	Employees 7,5692% decrease	Employees 8,5201% increase	Employees 4,595
Valuation ($)	Valuation ($) 94.2 m	Valuation ($) 121.4 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $1.3m (FY, 2024)	Revenue (est.) $12b (FY, 2025)	Revenue (est.) $7.9b (FY, 2020)	Revenue (est.) N/A	Revenue (est.) ¥3.7b (FY, 2024)
Cost of goods	Cost of goods N/A	Cost of goods $1.7b (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥533.6m (FY, 2024)
Gross profit	Gross profit N/A	Gross profit $10.4b (FY, 2025)	Gross profit $4.5b (FY, 2020)	Gross profit N/A	Gross profit ¥3.2b (FY, 2024)
Net income	Net income ($169.8m) (FY, 2024)	Net income N/A	Net income N/A	Net income N/A	Net income ¥482.7m (FY, 2024)
Funding
Total funding raised	Total funding raised $ 52m	Total funding raised $ 2.4m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A